550 related articles for article (PubMed ID: 27829671)
21. Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases.
Chen L; Lei X; Mahnke K
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891997
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
[TBL] [Abstract][Full Text] [Related]
23. The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
Safarzadeh E; Jadidi-Niaragh F; Motallebnezhad M; Yousefi M
Inflamm Res; 2016 Jul; 65(7):511-20. PubMed ID: 26960979
[TBL] [Abstract][Full Text] [Related]
24. Adenosine receptors: new therapeutic targets for inflammation in diabetic nephropathy.
Elsherbiny NM; Al-Gayyar MM
Inflamm Allergy Drug Targets; 2013 Jun; 12(3):153-61. PubMed ID: 23621447
[TBL] [Abstract][Full Text] [Related]
25. Adenosine A2A receptor agonists as anti-inflammatory agents.
Sullivan GW
Curr Opin Investig Drugs; 2003 Nov; 4(11):1313-9. PubMed ID: 14758770
[TBL] [Abstract][Full Text] [Related]
26. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
27. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Ohta A; Sitkovsky M
Nature; 2001 Dec 20-27; 414(6866):916-20. PubMed ID: 11780065
[TBL] [Abstract][Full Text] [Related]
28. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
29. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.
Ceeraz S; Nowak EC; Burns CM; Noelle RJ
Arthritis Res Ther; 2014; 16(5):469. PubMed ID: 25606596
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
31. Adenosine receptors and inflammation.
Blackburn MR; Vance CO; Morschl E; Wilson CN
Handb Exp Pharmacol; 2009; (193):215-69. PubMed ID: 19639284
[TBL] [Abstract][Full Text] [Related]
32. [Immune regulation via the generation of extracellular adenosine by CD73].
Tsukamoto H
Seikagaku; 2014 Dec; 86(6):766-9. PubMed ID: 25675814
[No Abstract] [Full Text] [Related]
33. Adenosine, an endogenous distress signal, modulates tissue damage and repair.
Fredholm BB
Cell Death Differ; 2007 Jul; 14(7):1315-23. PubMed ID: 17396131
[TBL] [Abstract][Full Text] [Related]
34. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis.
Montesinos MC; Yap JS; Desai A; Posadas I; McCrary CT; Cronstein BN
Arthritis Rheum; 2000 Mar; 43(3):656-63. PubMed ID: 10728760
[TBL] [Abstract][Full Text] [Related]
35. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms.
Haskó G; Kuhel DG; Chen JF; Schwarzschild MA; Deitch EA; Mabley JG; Marton A; Szabó C
FASEB J; 2000 Oct; 14(13):2065-74. PubMed ID: 11023991
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity.
Azambuja JH; Ludwig N; Braganhol E; Whiteside TL
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739402
[TBL] [Abstract][Full Text] [Related]
37. The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia.
D'Antongiovanni V; Fornai M; Pellegrini C; Benvenuti L; Blandizzi C; Antonioli L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708507
[TBL] [Abstract][Full Text] [Related]
38. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
39. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
Quast C; Alter C; Ding Z; Borg N; Schrader J
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
[TBL] [Abstract][Full Text] [Related]
40. [Neuroprotective mechanisms of adenosine action on CNS neurons].
Zalewska-Kaszubska J
Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
